Global Inhalation Anesthesia Market Research Report: Information by Product (Sevoflurane, Isoflurane, Desflurane), Application (Induction, Maintenance) and Region - Global Forecast till 2025

Q: Which North American country would lead the American inhalation anesthesia market?

The US will lead the American inhalation anesthesia market.. Read More

ID: MRFR/HC/6587-HCR | February 2021 | Region: Global | 90 pages

The global inhalation anesthesia market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 1.12 billion in 2018 and is projected to register a CAGR of 3.8% over the forecast period. , Inhalational anesthetics are used for the induction and maintenance of general anesthesia as well as sedation. They are usually preferred for maintenance because they allow more precise control of the anesthetic state and do so at low cost., The increasing geriatric population is one of the key factors driving the inhalation anesthesia market as they are highly prone to degenerative diseases and chronic illnesses, which eventually leads to a rise in surgeries and therapeutics. According to WHO, it is estimated that the world’s population aged 60 years and older are likely to double from 12% to 22% by 2050. , Various other factors such as the rise in surgical procedures, rising prevalence of cardiovascular and respiratory system-related diseases along with technological advancements, and a rise in regulatory approvals drive the growth of the market. , However, the increasing concern about greenhouse gas emissions will hamper market growth over the forecast period., Segmentation, The global inhalation anesthesia market is segmented based on product, application, and region. , The global market for inhalation anesthesia, by product, is segmented into sevoflurane, isoflurane, and desflurane. , Based on application, the market is segmented into induction and maintenance., In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region., The inhalation anesthesia market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada., The European inhalation anesthesia market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The inhalation anesthesia market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The inhalation anesthesia market in the Middle East & Africa has been segmented into the Middle East and Africa., Key Players, , Baxter International Inc., Halocarbon Products Corporation, Hikima Pharmaceuticals plc.

Market Scenario

Inhalational anesthetics are used for the induction and maintenance of general anesthesia as well as sedation. They are usually preferred for maintenance because they allow more precise control of the anesthetic state and do so at low cost.

The increasing geriatric population is one of the key factors driving the inhalation anesthesia market as they are highly prone to degenerative diseases and chronic illnesses, which eventually leads to a rise in surgeries and therapeutics. According to WHO, it is estimated that the world’s population aged 60 years and older are likely to double from 12% to 22% by 2050.

Various other factors such as the rise in surgical procedures, rising prevalence of cardiovascular and respiratory system-related diseases along with technological advancements, and a rise in regulatory approvals drive the growth of the market.

However, the increasing concern about greenhouse gas emissions will hamper market growth over the forecast period.

Segmentation

The global inhalation anesthesia market is segmented based on product, application, and region.

The global market for inhalation anesthesia, by product, is segmented into sevoflurane, isoflurane, and desflurane.

Based on application, the market is segmented into induction and maintenance.

In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.

The inhalation anesthesia market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European inhalation anesthesia market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The inhalation anesthesia market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The inhalation anesthesia market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key Players

Baxter International Inc.

Halocarbon Products Corporation

Hikima Pharmaceuticals plc.

Lunan Pharmaceutical Group Co. Ltd

Piramal Enterprises Limited

Jiangsu Hengrui Medicine Co. Ltd

Fresenius Kabi AG

AbbVie Inc.

Regional Market Summary

Global Inhalation Anesthesia Market Share (%), by Region, 2018

Sources: MRFR Analysis

The Americas dominated the global market for inhalation anesthesia owing to the rising geriatric population within the region. As per the data suggested by the United Census Bureau, by 2060, the US is projected to grow by 79 million people, from about 326 million today to 404 million. The population is projected to cross the 400-million threshold in 2058. Additionally, according to the WHO, in the US, more than 20% of the total population is likely to be aged 65 years or over by 2030. Moreover, rising cases of surgical procedures along with the participation of market players are also strongly impacting the growth of the Americas inhalation anesthesia market. For instance, according to the American Society for Aesthetic Plastic Surgery, around 1, 542, 67 surgical cosmetic procedures were conducted in 2017. Similarly, according to the Center for Diseases Control and Prevention, approximately 46.5 million surgical procedures are performed every year in the US.

In 2018, it was estimated that Europe stood second in the global inhalation anesthesia market. Technological advancements, along with the availability of funding opportunities in research and innovation, will support market growth.

Asia-Pacific (APAC) is expected to represent the phenomenal market growth throughout the forecast period due to rising prevalence of chronic conditions, growing awareness about medications, and increasing healthcare expenditure. During 2016-2017, Australia spent nearly USD181 billion on health, which is more than USD 7,400 per person and 10% of overall economic activity.

On the other hand, the Middle East and Africa held the least share in the global inhalation anesthesia market due to the low economic development, especially within the African region.

Market Segmentation

Global Inhalation Anesthesia Market, by Product

Sevoflurane

Isoflurane

Desflurane

Global Inhalation Anesthesia Market, by Application

Induction

Maintenance

Intended Audience

Medical devices companies

Government and private laboratories

Research and development (R&D) companies

Research laboratories

Market research and consulting service providers

Frequently Asked Questions (FAQ) :

What was the inhalation anesthesia market valuation in 2018?

The inhalation anesthesia market in 2018 was USD 1.12 billion.

What would be the projected CAGR for the inhalation anesthesia market during the forecast period of 2019 to 2024?

The inhalation anesthesia market would grow with a CAGR of 3.8% CAGR during the forecast period of 2019 to 2024.

What could arrest the growth rate of the inhalation anesthesia market?

The concern regarding increasing greenhouse gas emissions can deter the inhalation anesthesia market growth rate.

Which North American country would lead the American inhalation anesthesia market?

The US will lead the American inhalation anesthesia market.

Which region would record the fastest growth rate for the inhalation anesthesia market?

The Asia Pacific inhalation anesthesia market would be the fastest-growing region.

Table of Contents
Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Macroeconomic Indicators

4.5 Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Opportunities

5.4 Pricing Analysis

Chapter 6. Global Inhalation Anesthesia Market, by Product

6.1 Introduction

6.2 Sevoflurane